ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
48 announcements with these filters
Meghmani Organics Limited (MOL) has received approval for a Scheme of Amalgamation to merge Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited into itself. The NCLT-convened meeting of shareholders is scheduled for June 6, 2026. This restructuring aims to consolidate group operations and streamline the corporate structure subject to final regulatory and tribunal approvals.
Meghmani Organics Limited announced an NCLT-convened meeting for unsecured creditors on June 6, 2026, to approve the amalgamation of Kilburn Chemicals and Meghmani Crop Nutrition. The total unsecured creditor value involved is ₹546.76 Crore. This merger aims to simplify group structure and achieve operational synergies through full integration of subsidiary operations.
Meghmani Organics Limited announced an NCLT-convened meeting of its secured creditors on June 06, 2026, to approve the Scheme of Amalgamation with Kilburn Chemicals and Meghmani Crop Nutrition. The merger aims to simplify group structure and create operational synergies. Voting will be conducted through remote e-voting and during the video-conference meeting.
Meghmani Organics Limited's subsidiary, MCNL, received Ministry of Agriculture approval to manufacture Nano DAP, Nano NPK, and Nano Zinc fertilizers. Production will occur at the existing Sanand facility in Gujarat without additional capital expenditure. Commercial operations are slated to begin during the upcoming Kharif season, strengthening the company's sustainable crop nutrition portfolio.
Meghmani Organics Limited received approval from the Ministry of Agriculture and Farmers Welfare to manufacture Nano DAP, Nano NPK, and Nano Zinc. Production will occur at its Sanand facility in Gujarat via subsidiary Meghmani Crop Nutrition Limited. Commercial production is slated for the upcoming Kharif season without requiring additional capital expenditure.
Meghmani Organics Limited announced an NCLT-convened meeting on June 6, 2026, for shareholders to approve the amalgamation of Kilburn Chemicals and Meghmani Crop Nutrition. The merger aims to simplify the group structure and achieve operational synergies. Remote e-voting is scheduled from June 3 to June 5, 2026.
Meghmani Organics Limited announced a corrected schedule for NCLT-directed meetings of equity shareholders, secured creditors, and unsecured creditors on June 06, 2026. This correction addresses a typographical error in a previous intimation. Schedules for Kilburn Chemicals and Meghmani Crop Nutrition remain unchanged. Meetings will be held via video conferencing.
Meghmani Organics Limited received an NCLT order directing meetings on June 06, 2026, to approve the amalgamation of Kilburn Chemicals and Meghmani Crop Nutrition. The merger aims to consolidate group entities, with meetings for shareholders and creditors conducted via video conferencing.
Meghmani Organics Limited has received a credit rating update from CRISIL for its ₹1094 Crore bank facilities. While ratings were reaffirmed at 'CRISIL A' and 'CRISIL A1', the long-term outlook was revised from 'Stable' to 'Negative'.
Meghmani Organics Ltd has scheduled a Board of Directors meeting on May 09, 2026. The board will consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
Meghmani Organics Limited has re-appointed Mr. Manubhai Patel, Prof. (Dr) Ganapati Yadav, and Ms. Urvashi Shah as Non-Executive Non-Independent Directors. The appointments are effective from May 5, 2026, for a tenure of 36 months, ensuring board continuity.
Meghmani Organics Limited announced the results of its postal ballot conducted via remote e-voting. Shareholders approved the reappointment of Mr. Manubhai Patel, Prof. (Dr) Ganapati Yadav, and Ms. Urvashi Shah as Independent Directors for second three-year terms effective May 5, 2026. All resolutions were passed with the requisite majority.
Meghmani Organics Limited shareholders approved the re-appointment of three Independent Directors—Mr. Manubhai Patel, Prof. Ganapati Yadav, and Ms. Urvashi Shah—for a second three-year term effective May 5, 2026. These appointments ensure continuity of experienced leadership and robust corporate governance on the Board.
Meghmani Organics Limited announced the successful passage of three special resolutions via postal ballot with requisite majority. Shareholders approved the reappointment of Mr. Manubhai Patel, Prof. (Dr) Ganapati Yadav, and Ms. Urvashi Shah as Independent Directors for second three-year terms effective May 5, 2026.
Meghmani Organics Limited's subsidiary, Kilburn Chemicals Limited, has seen its credit rating outlook revised to 'Positive' from 'Negative' by India Ratings & Research. The revision applies to bank loan facilities totaling ₹274.20 Crore (INR 2,742 million), reflecting improved creditworthiness and operational outlook for the subsidiary.
Meghmani Organics Limited approved the amalgamation of its wholly-owned subsidiaries, Kilburn Chemicals and Meghmani Crop Nutrition, into itself. The merger aims to simplify the group structure, optimize resources, and derive operational synergies. There will be no change in the listed entity's shareholding pattern as a result of this internal restructuring.
Meghmani Organics Limited has approved the amalgamation of its wholly owned subsidiaries, Kilburn Chemicals and Meghmani Crop Nutrition, with itself. The merger aims to simplify the group structure and derive operational synergies. As the entities are wholly owned, no new shares will be issued as consideration.
Meghmani Organics Limited's board approved the amalgamation of its wholly-owned subsidiaries, Kilburn Chemicals and Meghmani Crop Nutrition, with itself. The merger aims to simplify the group structure and achieve operational synergies. No shares will be issued as the subsidiaries are wholly owned, leaving the parent company's shareholding pattern unchanged.